Alison Pearce

2.3k total citations · 1 hit paper
76 papers, 1.5k citations indexed

About

Alison Pearce is a scholar working on Oncology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Alison Pearce has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 31 papers in Economics and Econometrics and 24 papers in General Health Professions. Recurrent topics in Alison Pearce's work include Health Systems, Economic Evaluations, Quality of Life (25 papers), Economic and Financial Impacts of Cancer (14 papers) and Global Cancer Incidence and Screening (13 papers). Alison Pearce is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (25 papers), Economic and Financial Impacts of Cancer (14 papers) and Global Cancer Incidence and Screening (13 papers). Alison Pearce collaborates with scholars based in Australia, United Kingdom and Ireland. Alison Pearce's co-authors include Rosalie Viney, Marion Haas, Philip Haywood, Robyn L. Ward, Linda Sharp, Chris Brown, Sallie‐Anne Pearson, Bogda Koczwara, Floortje Mols and Billingsley Kaambwa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alison Pearce

69 papers receiving 1.5k citations

Hit Papers

Incidence and severity of self-reported chemotherapy side... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Pearce Australia 20 562 419 214 212 201 76 1.5k
Nora B. Henrikson United States 27 754 1.3× 405 1.0× 383 1.8× 273 1.3× 179 0.9× 93 2.3k
André Ilbawi Switzerland 20 976 1.7× 433 1.0× 259 1.2× 402 1.9× 153 0.8× 61 2.2k
Panagiotis Mavros United States 22 259 0.5× 516 1.2× 234 1.1× 128 0.6× 189 0.9× 59 2.9k
Su‐Ying Liang United States 21 436 0.8× 432 1.0× 446 2.1× 291 1.4× 83 0.4× 76 1.4k
M. Elske van den Akker‐van Marle Netherlands 29 448 0.8× 291 0.7× 340 1.6× 332 1.6× 239 1.2× 155 2.9k
Swann Arp Adams United States 29 984 1.8× 308 0.7× 597 2.8× 558 2.6× 139 0.7× 122 2.3k
Céu Mateus United Kingdom 22 543 1.0× 375 0.9× 465 2.2× 239 1.1× 63 0.3× 101 2.0k
Steven Leadbetter United States 19 629 1.1× 124 0.3× 287 1.3× 299 1.4× 102 0.5× 26 1.7k
Maria Mathews Canada 21 305 0.5× 330 0.8× 701 3.3× 376 1.8× 178 0.9× 130 1.8k
Folakemi T. Odedina United States 21 586 1.0× 176 0.4× 247 1.2× 244 1.2× 65 0.3× 83 1.4k

Countries citing papers authored by Alison Pearce

Since Specialization
Citations

This map shows the geographic impact of Alison Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Pearce more than expected).

Fields of papers citing papers by Alison Pearce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Pearce. The network helps show where Alison Pearce may publish in the future.

Co-authorship network of co-authors of Alison Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Pearce. A scholar is included among the top collaborators of Alison Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Pearce. Alison Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pearce, Alison, et al.. (2025). Public Perspectives Around Prenatal Screening of Chromosomal Abnormalities: A Focus Group Study Comparing Metropolitan and Rural/Regional Areas in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 65(4). 506–517. 1 indexed citations
2.
Kong, Yek‐Ching, Phuong Bich Tran, Jérôme Vignat, et al.. (2025). Global paid and unpaid productivity losses due to cancer-related mortality. JNCI Journal of the National Cancer Institute. 117(12). 2612–2620.
3.
Pearce, Alison, et al.. (2024). Patient preferences for investigating cancer-related symptoms in Australian general practice: a discrete-choice experiment. British Journal of General Practice. 74(745). e517–e526. 1 indexed citations
4.
Norman, Richard, Amelia K. Smit, Anne Ε. Cust, et al.. (2024). Public Preferences for Genetic and Genomic Risk-Informed Chronic Disease Screening and Early Detection: A Systematic Review of Discrete Choice Experiments. Applied Health Economics and Health Policy. 23(3). 395–408. 3 indexed citations
5.
Goldsbury, David, Philip Haywood, Alison Pearce, et al.. (2024). Out‐of‐pocket health care expenses for people with and without cancer, New South Wales, 2020: a cross‐sectional study. The Medical Journal of Australia. 221(2). 94–102. 2 indexed citations
6.
Hanly, Paul, et al.. (2023). Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries. PharmacoEconomics. 41(9). 1093–1101. 8 indexed citations
9.
Zhang, Wei, Huiying Sun, Richard Sawatzky, et al.. (2022). Working From Home During the COVID-19 Pandemic. Journal of Occupational and Environmental Medicine. 64(11). e677–e684. 3 indexed citations
10.
Schoormans, Dounya, et al.. (2022). Work, daily activities and leisure after cancer. European Journal of Cancer Care. 31(4). e13596–e13596. 3 indexed citations
11.
Shaw, Joanne, et al.. (2021). Investigating the Association Between Self-Reported Comorbid Anxiety and Depression and Health Service Use in Cancer Survivors. PharmacoEconomics. 39(6). 681–690. 7 indexed citations
12.
Hanly, Paul, et al.. (2021). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. International Journal of Cancer. 150(4). 580–593. 21 indexed citations
13.
Arora, S. K., et al.. (2021). Patient Preferences for Anxiety and Depression Screening in Cancer Care: A Discrete Choice Experiment. Value in Health. 24(12). 1835–1844. 5 indexed citations
14.
Smith, Allan Ben, Phyllis Butow, Britt Klein, et al.. (2019). Development and usability evaluation of an online self‐management intervention for fear of cancer recurrence (iConquerFear). Psycho-Oncology. 29(1). 98–106. 43 indexed citations
15.
Pearce, Alison, Brendan Mulhern, Verity Watson, & Rosalie Viney. (2019). How Are Debriefing Questions Used in Health Discrete Choice Experiments? An Online Survey. Value in Health. 23(3). 289–293. 12 indexed citations
16.
Pearce, Alison, Linda Sharp, Paul Hanly, et al.. (2018). Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison. Cancer Epidemiology. 53. 27–34. 87 indexed citations
17.
Norman, Richard, Brendan Mulhern, Rosalie Viney, Nick Bansback, & Alison Pearce. (2016). The Impact of Duration on EQ‐5D‐5l Value Sets Derived from a Discrete Choice Experiment. Value in Health. 19(7). A828–A828. 1 indexed citations
18.
Pearce, Alison, Marion Haas, Rosalie Viney, Robyn L. Ward, & Philip Haywood. (2014). Rates of Chemotherapy Adverse-Events in Clinical Practice: Results From Prospective Cohort Study. Asia-Pacific Journal of Clinical Oncology. 10. 43–44. 1 indexed citations
19.
Thomas, Audrey Alforque, et al.. (2014). Distance from treating hospital and colorectal cancer survivors’ quality of life: a gendered analysis. Supportive Care in Cancer. 23(3). 741–751. 28 indexed citations
20.
Pearce, Alison, Kees Van Gool, Philip Haywood, & Marion Haas. (2012). Delays in access to affordable medicines: putting policy into perspective. Australian Health Review. 36(4). 412–418. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026